Showing results (251-260 of 325) with videos related to
Sort By:
Pageof 33
Antiviral Research|September 13, 2017
Raltegravir blocks the infectivity of red-fluorescent-protein (mCherry)-labeled HIV-1JR-FL in the setting of post-exposure prophylaxis in NOD/SCID/Jak3-/- mice transplanted with human PBMCsHiromi Ogata-Aoki, Nobuyo Higashi-Kuwata, Shin-Ichiro Hattori, et al.Journal of Medicinal Chemistry|May 16, 2018
Design and Synthesis of Highly Potent HIV-1 Protease Inhibitors Containing Tricyclic Fused Ring Systems as Novel P2 Ligands: Structure-Activity Studies, Biological and X-ray Structural AnalysisArun K Ghosh, Prasanth R Nyalapatla, Satish Kovela, et al.Journal of Virology|November 24, 2021
Highly Neutralizing COVID-19 Convalescent Plasmas Potently Block SARS-CoV-2 Replication and Pneumonia in Syrian HamstersYuki Takamatsu, Masaki Imai, Kenji Maeda, et al.Antiviral Research|May 12, 2006
Inhibition of HIV-1 replication by a peptide dimerization inhibitor of HIV-1 proteaseDavid A Davis, Cara A Brown, Kathleen E Singer, et al.Heliyon|February 2, 2024
High diagnostic accuracy of quantitative SARS-CoV-2 spike-binding-IgG assay and correlation with in vitro viral neutralizing activityNoriko Iwamoto, Yuki Takamatsu, Yusuke Asai, et al.The Journal of Biological Chemistry|April 26, 2013
The A128T resistance mutation reveals aberrant protein multimerization as the primary mechanism of action of allosteric HIV-1 integrase inhibitorsLei Feng, Amit Sharma, Alison Slaughter, et al.Bioorganic & Medicinal Chemistry|April 25, 2017
Design of novel HIV-1 protease inhibitors incorporating isophthalamide-derived P2-P3 ligands: Synthesis, biological evaluation and X-ray structural studies of inhibitor-HIV-1 protease complexArun K Ghosh, Margherita Brindisi, Prasanth R Nyalapatla, et al.Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|June 4, 2008
Effect of SLCO1B3 haplotype on testosterone transport and clinical outcome in caucasian patients with androgen-independent prostatic cancerAkinobu Hamada, Tristan Sissung, Douglas K Price, et al.Blood|December 6, 2012
PU.1 is a potent tumor suppressor in classical Hodgkin lymphoma cellsHiromichi Yuki, Shikiko Ueno, Hiro Tatetsu, et al.Antiviral Research|January 25, 2024
A lipid index for risk of hyperlipidemia caused by anti-retroviral drugsMari Shimura, Nobuyo Higashi-Kuwata, Asuka Fujiwara, et al.Pageof 33